Chemokines in host defense to Campylobacter jejuni
Chemokines in host defense to Campylobacter jejuni
批准号:
6675486
负责人:
Michael B Dwinell
金额:
$30.0万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-09-30 至 2005-08-31
关键词:
Campylobacter bacterial cytopathogenic effect bactericidal immunity biological signal transduction chemoattractants chemokine colitis enzyme linked immunosorbent assay gastrointestinal epithelium gene targeting host organism interaction interferon gamma microorganism culture mucosal immunity mutant nuclear factor kappa beta polymerase chain reaction tissue /cell culture virulence
中文摘要
描述(申请人提供):这份R21研究计划是为了响应“生物防御和新出现的传染病研究机遇”而提交的,NOT-AI-02-023,有两个特别的目的,旨在增加我们对空肠弯曲杆菌小肠结肠炎发病机制的了解。肠上皮由一种动态的物理屏障组成,该屏障维持着一系列活跃的固有宿主防御反应,以限制具有临床意义的食源性和水源性病原体的进入。这些机制包括调节趋化因子的产生,以协调适当的先天和获得性免疫效应器反应。空肠弯曲菌是世界上细菌性腹泻病的主要致病原因。然而,尽管对感染人类肠道并引发疾病的病理生理机制知之甚少,但肠道上皮细胞的相互作用是感染最常见的致病特征。这项研究的总体目标是获得关于空肠弯曲菌小肠结肠炎发病机制的新信息,并将作为重要的第一步,将重点放在肠道上皮细胞协调产生趋化因子作为重要的宿主防御机制。目标1的研究将检验这样一个假设,即空肠弯曲菌感染人肠道上皮细胞后,刺激中性粒细胞、树突状细胞和T淋巴细胞的趋化因子的产生,我们假设这些效应细胞协同作用来限制空肠弯曲菌进入体内。建立肠上皮细胞感染空肠弯曲菌的培养模型,并对其调控上皮细胞趋化因子产生的信号机制进行了研究。为了确定细菌的致病性,目标2中的研究将利用空肠弯曲菌突变株来检验特定的弯曲杆菌毒力因子诱导宿主上皮细胞趋化因子表达的假设。上皮性趋化因子的诱导表达将在空肠弯曲杆菌鞭毛突变体中进行测试,以及从基于启动子的TRAP方法中筛选出的突变体中筛选出来,以定义新的毒力因子。总之,这些研究将为调控肠上皮细胞趋化因子产生的细胞信号机制和细菌基因产物作为空肠弯曲菌的中心宿主防御功能提供新的见解。了解肠上皮宿主防御人类空肠弯曲菌感染的细胞和生化机制对于制定预防性治疗策略以调节宿主与病原体的相互作用以利于宿主是至关重要的。
英文摘要
DESCRIPTION (provided by applicant): This R21 research proposal, submitted in response to "Biodefense and Emerging Infectious Diseases Research Opportunities", NOT-AI-02-023, has two specific aims designed to increase our understanding of the pathogenesis of Campylobacter jejuni enterocolitis. The intestinal epithelium comprises a dynamic physical barrier that maintains an active repertoire of innate host defense responses to limit entry of clinically significant food- and water-borne pathogens. These mechanisms include the regulated production of chemokines to coordinate the appropriate innate and adaptive immune effector response. C. jejuni is a leading cause of bacterial diarrheal disease in the world. However, while relatively little is known of the pathophysiologic mechanisms employed to infect the human intestinal tract and elicit disease, interaction at the intestinal epithelium is the most common pathogenic feature of infection. The overall objective of this research proposal is to obtain novel information on the mechanisms of pathogenesis to C. jejuni enterocolitis and will, as an important first step, focus on the coordinated production of chemokines by the cells of the intestinal epithelium as a significant host defense mechanism. Studies in Aim 1 will test the hypothesis that C. jejuni infection of human intestinal epithelial cells stimulates production of chemokines for neutrophils, dendritic cells and T lymphocytes, effectors cells that we postulate act in concert to limit C. jejuni entry in vivo. A culture model intestinal epithelium will be infected with C. jejuni and the signaling mechanisms regulating epithelial chemokine production assessed. To define bacterial pathogenicity, studies in Aim 2 will utilize C. jejuni mutants to test the hypothesis that specific Campylobacter virulence factors induce host epithelial cell chemokine expression. Induction of epithelial chemokine expression will be tested in C. jejuni flagella mutants, as well as mutants selected from candidates revealed from a promoter trap-based approach to define novel virulence factors. Together, these studies will provide new insights into the cellular signaling mechanisms and bacterial gene products regulating intestinal epithelial chemokine production as a central host defense function to C. jejuni. Understanding the cellular and biochemical mechanisms of intestinal epithelial host defense to human C. jejuni infection are central to the development of preventative therapeutic strategies to modulate host-pathogen interactions to favor the host.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Structure-based inhibition of chemokine signaling in the inflamed pancreas
-
批准号:10656002
-
项目类别:
-
资助金额:$66.27万
-
财政年份:2023
-
负责人:Michael B Dwinell
-
依托单位:
Biased chemokine receptor signaling in cancer progression
-
批准号:10077789
-
项目类别:
-
资助金额:$39.23万
-
财政年份:2019
-
负责人:Michael B Dwinell
-
依托单位:
Biased chemokine receptor signaling in cancer progression
-
批准号:10541844
-
项目类别:
-
资助金额:$38.38万
-
财政年份:2019
-
负责人:Michael B Dwinell
-
依托单位:
Biased chemokine receptor signaling in cancer progression
-
批准号:10321201
-
项目类别:
-
资助金额:$38.39万
-
财政年份:2019
-
负责人:Michael B Dwinell
-
依托单位:
Targeting pancreatic cancer energy metabolism, tumor growth, and metastasis
-
批准号:8696182
-
项目类别:
-
资助金额:$52.62万
-
财政年份:2014
-
负责人:Michael B Dwinell
-
依托单位:
Targeting pancreatic cancer energy metabolism, tumor growth, and metastasis
-
批准号:9281690
-
项目类别:
-
资助金额:$51.58万
-
财政年份:2014
-
负责人:Michael B Dwinell
-
依托单位:
Targeting pancreatic cancer energy metabolism, tumor growth, and metastasis
-
批准号:8883430
-
项目类别:
-
资助金额:$52.25万
-
财政年份:2014
-
负责人:Michael B Dwinell
-
依托单位:
NIDDK Research Education Program
-
批准号:8474410
-
项目类别:
-
资助金额:$5.5万
-
财政年份:2013
-
负责人:Michael B Dwinell
-
依托单位:
NIDDK Research Education Program
-
批准号:8738644
-
项目类别:
-
资助金额:$5.48万
-
财政年份:2013
-
负责人:Michael B Dwinell
-
依托单位:
NIDDK Research Education Program
-
批准号:9346649
-
项目类别:
-
资助金额:$5.43万
-
财政年份:2013
-
负责人:Michael B Dwinell
-
依托单位:
NIDDK Research Education Program
-
批准号:9126555
-
项目类别:
-
资助金额:$5.43万
-
财政年份:2013
-
负责人:Michael B Dwinell
-
依托单位:
Epithelial CXCR4 in a Mucosal Communication Network
-
批准号:8069072
-
项目类别:
-
资助金额:$32.9万
-
财政年份:2010
-
负责人:Michael B Dwinell
-
依托单位:
EPITHELIAL CXCR4 IN A MUCOSAL COMMUNICATION NETWORK
-
批准号:7850314
-
项目类别:
-
资助金额:$1.35万
-
财政年份:2009
-
负责人:Michael B Dwinell
-
依托单位:
EPITHELIAL CXCR4 IN A MUCOSAL COMMUNICATION NETWORK
-
批准号:7580914
-
项目类别:
-
资助金额:$26.47万
-
财政年份:2005
-
负责人:Michael B Dwinell
-
依托单位:
EPITHELIAL CXCR4 IN A MUCOSAL COMMUNICATION NETWORK
-
批准号:6920569
-
项目类别:
-
资助金额:$28.48万
-
财政年份:2005
-
负责人:Michael B Dwinell
-
依托单位:
EPITHELIAL CXCR4 IN A MUCOSAL COMMUNICATION NETWORK
-
批准号:7217916
-
项目类别:
-
资助金额:$25.15万
-
财政年份:2005
-
负责人:Michael B Dwinell
-
依托单位:
EPITHELIAL CXCR4 IN A MUCOSAL COMMUNICATION NETWORK
-
批准号:7385964
-
项目类别:
-
资助金额:$26.47万
-
财政年份:2005
-
负责人:Michael B Dwinell
-
依托单位:
EPITHELIAL CXCR4 IN A MUCOSAL COMMUNICATION NETWORK
-
批准号:7064223
-
项目类别:
-
资助金额:$27.81万
-
财政年份:2005
-
负责人:Michael B Dwinell
-
依托单位:
Chemokines in host defense to Campylobacter jejuni
-
批准号:6803523
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2003
-
负责人:Michael B Dwinell
-
依托单位:
CHEMOKINE RECEPTOR EXPRESSION ON INTESTINAL EPITHELIUM
-
批准号:6462951
-
项目类别:
-
资助金额:$3.41万
-
财政年份:2000
-
负责人:Michael B Dwinell
-
依托单位: